BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

CeNeRx BioPharma, Inc. 

270 Cornerstone Drive
Suite 103
Cary  North Carolina  27519  U.S.A.
Phone: 866-287-2622 Fax:


SEARCH JOBS


Industry
Pharmaceutical






 Company News
CeNeRx BioPharma, Inc. Completes $4.85 Million Financing 12/9/2011 7:13:16 AM    More...
CeNeRx BioPharma, Inc. Announces FDA IND Approval for its Neuroprotective Agent in Chemotherapy-Induced Neuropathy and Results From First Human Study 2/9/2011 7:53:59 AM    More...
CeNeRx BioPharma, Inc. Initiates Phase II Trial of TriRima(TM) as Monotherapy in Treatment Resistant Depression 1/6/2011 6:39:35 AM    More...
CeNeRx BioPharma, Inc.'s Novel Antidepressant TriRima(TM) Demonstrates Key Safety Benefit in Pivotal Safety Study 11/2/2010 10:55:59 AM    More...
CeNeRx BioPharma, Inc. Completes $13 Million Series C Financing 8/13/2010 7:02:04 AM    More...
New Clinical Study Shows Anxiolytic Potential of CeNeRx BioPharma, Inc.'s Novel Mechanism HPA Axis Modulator Compounds 1/12/2010 2:31:07 PM    More...
Publication in Neuropsychopharmacology Confirms CeNeRx BioPharma, Inc.'s Novel RIMA Antidepressant TriRima(TM) Selectively and Reversibly Inhibits MAO-A 12/7/2009 2:12:13 PM    More...
CeNeRx BioPharma, Inc. Completes $9 Million Financing 6/16/2009 7:24:03 AM    More...
CeNeRx BioPharma, Inc. Obtains Rights to Novel Drug Candidate for Prevention and Treatment of Neurodegeneration Disorders 6/16/2009 7:22:51 AM    More...
CeNeRx BioPharma, Inc. Awarded New Patent for its Innovative Compounds That Selectively Target Peripheral Cannabinoid Receptors 4/1/2009 9:07:47 AM    More...
12

//-->